Chromocell Hits Stock Markets Following $6.6M IPO
By Jade Martinez-Pogue · February 16, 2024, 5:09 PM EST
Clinical-stage biotechnology company Chromocell Therapeutics Corp. began trading publicly on Friday after raising $6.6 million in its initial public offering, becoming the latest in a flurry of biotech IPOs....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login